About Us
OPTIMIZED BY EVOLUTION
Wugen, Inc. is a pivotal-stage American-born biotechnology company advancing the next generation of off-the-shelf cell therapies
Our allogeneic therapies are derived from healthy donor cells and are engineered to deliver robust anti-tumor activity. With our proprietary CAR-T platform, Wugen is addressing critical unmet needs in hematologic malignancies.
Our US-based manufacturing is optimized for scale, consistency, and rapid deployment, enabling the delivery of transformative therapies to patients with speed and precision.
Next in our story
Copyright © 2025 Wugen. All Rights Reserved.
Privacy Notice
a COGNEO design